OR WAIT null SECS
May 09, 2018
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
Takeda expands its global and therapy base with announced acquisition of Shire.
May 08, 2018
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
May 07, 2018
The data and analytics company reports on the anticipated uptake of Humira (adalimumab) biosimilars in the EU once they are launched in 2018.
May 01, 2018
As Astellas Pharma winds down its Agensys research operations, the company sells the Santa Monica, CA, facility to Gilead.
The companies plan to advance programs for dementia and other neurological conditions.
April 30, 2018
The company received a complete response letter from FDA in response to the biologics license application for a proposed trastuzumab biosimilar.
April 20, 2018
LNC Therapeutics has appointed a new CEO and is strengthening its R&D for gut microbiome-based drugs.
April 19, 2018
The transaction is part of Merck KGaA’s strategy to actively shape its product portfolio and focus on innovation-driven business.
Global investment firm Advent to acquire and invest in Sanofi’s European generics business, Zentiva, to boost its position in European market.